These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 1847546

  • 1. [Direct cervical myelography using iotrolan 300].
    Volle E, Hedde JP, Gormanns R.
    Rofo; 1991 Feb; 154(2):197-201. PubMed ID: 1847546
    [Abstract] [Full Text] [Related]

  • 2. Tolerance of iotrolan 190 and cerebrospinal fluid-diluted iotrolan 300 at the same iodine concentration in lumbar myelography.
    Wenzel-Hora BI, Potthoff PC, Jänicke UA.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Feb; 128():148-52. PubMed ID: 2568783
    [Abstract] [Full Text] [Related]

  • 3. Clinical trials with iotrolan in myelographic and computed tomography applications in the United States.
    Goldstein HA, Pfennig D.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Feb; 128():167-70. PubMed ID: 2568788
    [Abstract] [Full Text] [Related]

  • 4. Iotrolan versus iopamidol: a controlled, multicenter, double-blind study of lumbar and direct cervical myelography.
    Ringel K, Klotz E, Wenzel-Hora BI.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Feb; 128():153-7. PubMed ID: 2568784
    [Abstract] [Full Text] [Related]

  • 5. Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs.
    van Bree H, Van Rijssen B, Van Ham L.
    Am J Vet Res; 1991 Jun; 52(6):926-33. PubMed ID: 1883098
    [Abstract] [Full Text] [Related]

  • 6. Intracranial iotrolan distribution following cervical myelography. Postmyelographic registration of adverse effects, psychometric assessment and electroencephalographic recording.
    Fiirgaard B, Madsen HH, Svare U, Eriksen FB, Skjødt T, Zeeberg I.
    Acta Radiol; 1995 Jan; 36(1):77-81. PubMed ID: 7833174
    [Abstract] [Full Text] [Related]

  • 7. [The new nonionic contrast preparation for myelography iotrolan].
    Sviridov NK.
    Zh Vopr Neirokhir Im N N Burdenko; 1994 Jan; (2):35-6. PubMed ID: 8209595
    [No Abstract] [Full Text] [Related]

  • 8. Neural tolerance of iotrolan 300 in ascending cervical myelography: results of a multicenter study.
    Behrends B, Albrecht A, Bingas B, Becker H, Brunke J, von Einsiedel H, Mariss G, Schmidt K, Thun F, Valavanis A.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Jan; 128():171-5. PubMed ID: 2568789
    [Abstract] [Full Text] [Related]

  • 9. Comparative clinical study with iotrolan versus metrizamide in lumbar myelography.
    Inoue S, Watanabe T, Yamamura H.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Jan; 128():161-6. PubMed ID: 2568787
    [Abstract] [Full Text] [Related]

  • 10. Iotrolan. The first dimeric non-ionic contrast medium for the subarachnoid space.
    Wenzel-Hora BI.
    Acta Radiol Suppl; 1986 Jan; 369():545-8. PubMed ID: 2980554
    [Abstract] [Full Text] [Related]

  • 11. Iohexol: summary of North American and European clinical trials in adult lumbar, thoracic, and cervical myelography with a new nonionic contrast medium.
    Shaw DD, Bach-Gansmo T, Dahlstrom K.
    Invest Radiol; 1985 Jan; 20(1 Suppl):S44-50. PubMed ID: 3882616
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tolerance to iotrolan after subarachnoid injection in animals.
    Press WR, Mützel W, Schöbel C.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Jan; 128():126-33. PubMed ID: 2568780
    [Abstract] [Full Text] [Related]

  • 14. [Intracranial distribution of iohexol and iotrolan after cervical myelography].
    Fiirgaard B, Madsen HH, Svare U, Skjødt T, Zeeberg I.
    Ugeskr Laeger; 1995 Jul 03; 157(27):3901-4. PubMed ID: 7645065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue distribution and excretion of iotrolan after intravenous and suboccipital injections in animals.
    Weinmann HJ, Scholz P, Mützel W.
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1989 Jul 03; 128():206-10. PubMed ID: 2568796
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.